AARTIPHARM — Aarti Pharmalabs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹79.22bn
- IN₹86.67bn
- IN₹18.19bn
Annual cashflow statement for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | C2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,554 | 2,608 | 3,005 | 3,607 | 2,277 |
| Depreciation | |||||
| Non-Cash Items | 103 | 217 | 245 | 405 | 838 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,515 | -950 | -1,818 | -1,579 | -1,539 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -437 | 2,501 | 2,164 | 3,301 | 2,619 |
| Capital Expenditures | -1,412 | -1,197 | -1,988 | -4,439 | -4,483 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 24.1 | -381 | -158 | 314 | 176 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,387 | -1,578 | -2,146 | -4,125 | -4,307 |
| Financing Cash Flow Items | -120 | -211 | -172 | -245 | -387 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,604 | -1,635 | 97.2 | 654 | 1,706 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 779 | -712 | 115 | -169 | 18 |